SCHEMBL4779263

SCHEMBL4779263

CON(C(=O)O)S(=O)(=O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAMTS4 O75173 1/20 0.50
MMP2 P08253 7/20 0.49
MMP9 P14780 6/20 0.49
MMP14 P50281 5/20 0.49
MMP3 P08254 4/20 0.49
MMP8 P22894 4/20 0.49
MMP13 P45452 4/20 0.49
MMP16 P51512 3/20 0.49
MMP12 P39900 2/20 0.49
PKM P14618 1/20 0.47
MMP1 P03956 3/20 0.46
PTGES O14684 4/20 0.46
ALOX5 P09917 4/20 0.46
ADAM17 P78536 2/20 0.45
NPC1 O15118 1/20 0.45
MTOR P42345 1/20 0.45
RAB9A P51151 1/20 0.45
MMP7 P09237 1/20 0.45
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6792747 0.75 PKM (0.58) ADAMTS4MMP2MMP9MMP14MMP3
SCHEMBL25437664 0.73 HSD11B1 (0.51) PTGESKDM4EMAPTKMT2A
SCHEMBL4073854 0.72 LMNA (0.63) ADAMTS4PKMNPC1RAB9AKDM4E
SCHEMBL15705805 0.72 MMP1 (0.51) ADAMTS4MMP2MMP9MMP14MMP3
Biphenyl SCHEMBL6746212 0.72 ALDH1A1 (0.48) ADAMTS4MMP2MMP9MMP14MMP3
SCHEMBL15705623 0.71 DAGLA (0.58) MMP2MMP9MMP14MMP3MMP8
Hydrochloric Acid SCHEMBL28477859 0.71 LMNA (0.61) ADAMTS4PKMNPC1RAB9AKDM4E
SCHEMBL15705773 0.70 MMP1 (0.54) ADAMTS4MMP2MMP9MMP14MMP3
SCHEMBL8761424 0.69 CA1 (0.54) MMP2MMP14PKMMMP7
SCHEMBL6794824 0.68 CA12 (0.73) ADAMTS4PKMKDM4EMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008024784-A1 ALKYLSULFONAMIDE-SUBSTITUTED TRIAZOLES AS MATRIX METALLOPROTEASE INHIBITORS ARRAY BIOPHARMA, INC. (US) 2008-02-28 WO disclosed